- Home
- / Rocket Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Rocket Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$17.4
2024-10-29
Market Capitalization
$1.6 B
2024-10-29
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of goods sold | 1.2M | 1.2M | 2.3M | 1.5M | 1.1M | ||||||
| General and administrative expense | 17.9M | 17.5M | 27.9M | 41.8M | 58.8M | 73.3M | 102.0M | 86.5M | |||
| Operating expense total | 71.2M | 76.2M | 134.3M | 166.0M | 223.1M | 257.4M | 271.7M | 230.6M | |||
| EBIT | (20.4M) | (41.9M) | (26.7M) | (71.2M) | (76.2M) | (134.3M) | (167.2M) | (224.3M) | (259.7M) | (273.2M) | (231.7M) |
| Interest income | 89.0K | 443.0K | 819.0K | 1.7M | 3.4M | 2.2M | 3.1M | 3.9M | 5.3M | 8.3M | 3.2M |
| Interest expense | 89.0K | 1.9M | 1.9M | ||||||||
| Pre tax profit | (223.1M) | ||||||||||
| Net Income | (68.0M) | (42.9M) | (29.5M) | (74.5M) | (77.3M) | (139.7M) | (169.1M) | (221.9M) | (245.6M) | (258.7M) | (223.1M) |
| EPS | (3.3) | (2.9) | (2.7) | (2.0) |